• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整群随机交叉试验的报告:CONSORT 2010声明的扩展及解释与详述

Reporting of cluster randomised crossover trials: extension of the CONSORT 2010 statement with explanation and elaboration.

作者信息

McKenzie Joanne E, Taljaard Monica, Hemming Karla, Arnup Sarah J, Giraudeau Bruno, Eldridge Sandra, Hooper Richard, Kahan Brennan C, Li Tianjing, Moher David, Turner Elizabeth L, Grimshaw Jeremy M, Forbes Andrew B

机构信息

Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia

Clinical Epidemiology Programme, Ottawa Hospital Research Institute, Ottawa, ON, Canada.

出版信息

BMJ. 2025 Jan 6;388:e080472. doi: 10.1136/bmj-2024-080472.

DOI:10.1136/bmj-2024-080472
PMID:39761979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11701780/
Abstract

This article presents the CONSORT (consolidated standards of reporting trials) extension for cluster randomised crossover trials. A cluster randomised crossover trial involves randomisation of groups of individuals (known as clusters) to different sequences of interventions over time. The design has gained popularity in settings where cluster randomisation is required because it can largely overcome the loss in power due to clustering in parallel cluster trials. However, the design has many methodological complexities, requiring tailored reporting guidance. The guideline was developed using a survey and in-person consensus meeting, informed by a systematic review examining the quality of reporting in cluster randomised crossover trials and relevant CONSORT statements for individual, crossover, cluster, and stepped wedge designs. This article also provides recommended reporting items, along with explanations and examples.

摘要

本文介绍了针对整群随机交叉试验的CONSORT(试验报告统一标准)扩展版。整群随机交叉试验涉及将个体组(称为群组)随机分配到不同时间顺序的干预措施中。由于在需要整群随机化的情况下,该设计能够很大程度上克服平行整群试验中因整群效应导致的效能损失,因此受到广泛应用。然而,该设计存在许多方法学上的复杂性,需要有针对性的报告指南。该指南是通过一项调查和面对面的共识会议制定的,参考了一项系统评价,该评价考察了整群随机交叉试验的报告质量以及针对个体、交叉、整群和阶梯楔形设计的相关CONSORT声明。本文还提供了推荐的报告项目以及解释和示例。

相似文献

1
Reporting of cluster randomised crossover trials: extension of the CONSORT 2010 statement with explanation and elaboration.整群随机交叉试验的报告:CONSORT 2010声明的扩展及解释与详述
BMJ. 2025 Jan 6;388:e080472. doi: 10.1136/bmj-2024-080472.
2
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.CONSORT 2010 解释与说明:平行组随机试验报告的更新指南。
J Clin Epidemiol. 2010 Aug;63(8):e1-37. doi: 10.1016/j.jclinepi.2010.03.004. Epub 2010 Mar 25.
3
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.CONSORT 2010 解释和说明:报告平行组随机试验的更新指南。
Int J Surg. 2012;10(1):28-55. doi: 10.1016/j.ijsu.2011.10.001. Epub 2011 Oct 12.
4
CONSORT 2010 statement: extension to randomised pilot and feasibility trials.CONSORT 2010声明:随机对照试验和可行性试验的扩展
Pilot Feasibility Stud. 2016 Oct 21;2:64. doi: 10.1186/s40814-016-0105-8. eCollection 2016.
5
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.将CONSORT声明扩展至非药物治疗随机试验:解释与详述
Ann Intern Med. 2008 Feb 19;148(4):295-309. doi: 10.7326/0003-4819-148-4-200802190-00008.
6
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials.CONSORT-DEFINE解释与阐述:提高早期剂量探索性临床试验报告质量和影响力的建议
EClinicalMedicine. 2025 Jan 10;79:102987. doi: 10.1016/j.eclinm.2024.102987. eCollection 2025 Jan.
7
Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration.报告阶梯式楔形群随机试验:CONSORT 2010 声明的扩展,附有解释和说明。
BMJ. 2018 Nov 9;363:k1614. doi: 10.1136/bmj.k1614.
8
CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials.CONSORT-SPI 2018解释与阐述:社会和心理干预试验报告指南
Trials. 2018 Jul 31;19(1):406. doi: 10.1186/s13063-018-2735-z.
9
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.适应性设计 CONSORT 扩展(ACE)声明:一份带有解释和说明指南的清单,用于报告使用适应性设计的随机试验。
Trials. 2020 Jun 17;21(1):528. doi: 10.1186/s13063-020-04334-x.
10
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.适应性设计 CONSORT 扩展(ACE)声明:一份带有解释和说明指南的清单,用于报告使用适应性设计的随机试验。
BMJ. 2020 Jun 17;369:m115. doi: 10.1136/bmj.m115.

引用本文的文献

1
Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART Trial.急性心肌梗死后幽门螺杆菌筛查:群组随机交叉HELP-MI瑞典心脏注册研究试验
JAMA. 2025 Sep 1. doi: 10.1001/jama.2025.15047.
2
Development of a consensus extension of the estimands framework for cluster randomised trials (CRT-estimands): results from an international Delphi study.群组随机试验估计量框架共识扩展(CRT-估计量)的制定:一项国际德尔菲研究的结果
medRxiv. 2025 Jul 3:2025.07.03.25330799. doi: 10.1101/2025.07.03.25330799.
3
Augmented Enteral Protein During Critical Illness: The TARGET Protein Randomized Clinical Trial.

本文引用的文献

1
Demystifying estimands in cluster-randomised trials.剖析群组随机试验中的估计量。
Stat Methods Med Res. 2024 Jul;33(7):1211-1232. doi: 10.1177/09622802241254197. Epub 2024 May 23.
2
The estimands framework: a primer on the ICH E9(R1) addendum.估计量框架:ICH E9(R1)增编入门指南。
BMJ. 2024 Jan 23;384:e076316. doi: 10.1136/bmj-2023-076316.
3
Starting a conversation about estimands with public partners involved in clinical trials: a co-developed tool.与参与临床试验的公共合作伙伴就估计目标展开对话:一个共同开发的工具。
危重症期间强化肠内蛋白质补充:TARGET蛋白质随机临床试验
JAMA. 2025 Jun 11. doi: 10.1001/jama.2025.9110.
4
Preoxygenation With and Without Positive End-Expiratory Pressure in Lung-Healthy Volunteers: A Randomized Clinical Trial.健康肺志愿者中呼气末正压通气与非呼气末正压通气预给氧的随机临床试验
JAMA Netw Open. 2025 May 1;8(5):e2511569. doi: 10.1001/jamanetworkopen.2025.11569.
5
Guidelines for the content of statistical analysis plans in clinical trials: protocol for an extension to cluster randomized trials.临床试验统计分析计划内容指南:群组随机试验扩展方案
Trials. 2025 Feb 27;26(1):72. doi: 10.1186/s13063-025-08756-3.
Trials. 2023 Jul 6;24(1):443. doi: 10.1186/s13063-023-07469-9.
4
Best Practice Alerts Informed by Inpatient Opioid Intake to Reduce Opioid Prescribing after Surgery (PRIOR): A Cluster Randomized Multiple Crossover Trial.基于术后阿片类药物摄入量的最佳实践警报以减少手术后阿片类药物处方(PRIOR):一项集群随机多次交叉试验。
Anesthesiology. 2023 Aug 1;139(2):186-196. doi: 10.1097/ALN.0000000000004607.
5
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials.CONSORT危害声明2022:解释与阐述——随机对照试验中危害报告的更新指南
BMJ. 2023 Apr 24;381:e073725. doi: 10.1136/bmj-2022-073725.
6
FLUID trial: a hospital-wide open-label cluster cross-over pragmatic comparative effectiveness randomised pilot trial comparing normal saline to Ringer's lactate.FLUID 试验:一项在全院范围内进行的开放性标签、群组交叉、实用对比有效性随机对照预试验,比较生理盐水与乳酸林格氏液。
BMJ Open. 2023 Feb 3;13(2):e067142. doi: 10.1136/bmjopen-2022-067142.
7
Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.试验报告中结果报告指南:CONSORT-结果2022扩展版
JAMA. 2022 Dec 13;328(22):2252-2264. doi: 10.1001/jama.2022.21022.
8
Study protocol: The DAICY trial-dual versus single-antibiotic impregnated cement in primary hemiarthroplasty for femoral neck fracture-a register-based cluster-randomized crossover-controlled trial.研究方案:DAICY 试验-双 versus 单抗生素浸渍骨水泥在股骨颈骨折初次半髋关节置换术中的应用-基于注册的聚类随机交叉对照试验。
Acta Orthop. 2022 Oct 5;93:794-800. doi: 10.2340/17453674.2022.4819.
9
Accelerated partner therapy contact tracing for people with chlamydia (LUSTRUM): a crossover cluster-randomised controlled trial.加速性伴侣治疗接触者追踪在衣原体感染患者中的应用(LUSTRUM):一项交叉集群随机对照试验
Lancet Public Health. 2022 Oct;7(10):e853-e865. doi: 10.1016/S2468-2667(22)00204-3.
10
Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population.风筝锁(KiteLock)在重症监护病房控制导管相关并发症(CLiCK)的研究方案:一项多中心、集群随机、双盲、交叉临床试验,旨在研究一种新型锁液对重症监护人群中心导管相关并发症的影响。
Trials. 2022 Aug 30;23(1):719. doi: 10.1186/s13063-022-06671-5.